TY  - GEN
AU  - Béliard,Sophie
AU  - Boccara,Franck
AU  - Cariou,Bertrand
AU  - Carrié,Alain
AU  - Collet,Xavier
AU  - Farnier,Michel
AU  - Ferrières,Jean
AU  - Krempf,Michael
AU  - Peretti,Noël
AU  - Rabès,Jean-Pierre
AU  - Varret,Mathilde
AU  - Vimont,Alexandre
AU  - Charrière,Sybil
AU  - Bruckert,Eric
TI  - High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry
SN  - 1879-1484
PY  - 2019///1101
KW  - Adult
KW  - Anticholesteremic Agents
KW  - adverse effects
KW  - Biomarkers
KW  - blood
KW  - Cardiovascular Diseases
KW  - epidemiology
KW  - Cholesterol, LDL
KW  - Down-Regulation
KW  - Drug Therapy, Combination
KW  - Female
KW  - France
KW  - Genetic Predisposition to Disease
KW  - Heredity
KW  - Heterozygote
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - therapeutic use
KW  - Hyperlipoproteinemia Type II
KW  - Male
KW  - Middle Aged
KW  - PCSK9 Inhibitors
KW  - Pedigree
KW  - Phenotype
KW  - Proprotein Convertase 9
KW  - metabolism
KW  - Recurrence
KW  - Registries
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Secondary Prevention
KW  - methods
KW  - Serine Proteinase Inhibitors
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.atherosclerosis.2018.08.010
ER  -